The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Yellow fever vaccine
Abstract
Yellow fever, a mosquito-borne viral hemorrhagic fever, is one of the most lethal diseases of humankind. The etiologic agent is the prototype member of the genus Flavivirus, family Flaviviridae, a group of small, enveloped, positive-sense, single-strand RNA viruses. Approximately one in seven people who become infected develop a rapidly progressive illness, with hepatitis, renal failure, hemorrhage and cardiovascular shock, with a case fatality rate of 20-50%. Yellow fever occurs in sub-Saharan Africa and tropical South America, where it remains a continuing public health problem of varying magnitude, depending on the level of vaccination coverage in the human population and cyclical, ecologic and climatic factors that influence virus transmission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., & Harrison, S. C. (1995) · Nature · doi:10.1038/375291a0 · Cited by 1,437
Induced recruitment of NK cells to lymph nodes provides IFN-γ for TH1 priming
Martín-Fontecha, A., Thomsen, L. L., Brett, S., Gerard, C., Lipp, M., Lanzavecchia, A., & Sallusto, F. (2004) · Nature Immunology · doi:10.1038/ni1138 · Cited by 1,353
Structure of the dengue virus envelope protein after membrane fusion
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2004) · Nature · doi:10.1038/nature02165 · Cited by 1,203
Phylogeny of the Genus Flavivirus
Kuno, G., Chang, G.-J. J., Tsuchiya, K. R., Karabatsos, N., & Cropp, C. B. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.73-83.1998 · Cited by 1,105
Li, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092
A ligand-binding pocket in the dengue virus envelope glycoprotein
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832193100 · Cited by 1,061
Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures
Goodbourn, S., Didcock, L., & Randall, R. E. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-10-2341 · Cited by 977
Nucleotide Sequence of Yellow Fever Virus: Implications for Flavivirus Gene Expression and Evolution
Rice, C. M., Lenches, E. M., Eddy, S. R., Shin, S. J., Sheets, R. L., & Strauss, J. H. (1985) · Science · doi:10.1126/science.4023707 · Cited by 961
Research on Dengue during World War II
Sabin, A. B. (1952) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1952.1.30 · Cited by 951
Calisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893
DC-SIGN (CD209) Mediates Dengue Virus Infection of Human Dendritic Cells
Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M. A., Pattanapanyasat, K., Sarasombath, S., Birx, D. L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021840 · Cited by 890
Molecular biology of flaviviruses
Lindenbach, B. D., & Rice, C. M. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)59002-9 · Cited by 853
Global Climate Change and Emerging Infectious Diseases
Patz, J. A. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530270057032 · Cited by 757
Human skin Langerhans cells are targets of dengue virus infection
Wu, S.-J. L., Grouard-Vogel, G., Sun, W., Mascola, J. R., Brachtel, E., Putvatana, R., Louder, M. K., Filgueira, L., Marovich, M. A., Wong, H. K., et al. (2000) · Nature Medicine · doi:10.1038/77553 · Cited by 666
Dengue Virus Structural Differences That Correlate with Pathogenesis
Leitmeyer, K. C., Vaughn, D. W., Watts, D. M., Salas, R., Villalobos, I., de Chacon, Ramos, C., & Rico-Hesse, R. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4738-4747.1999 · Cited by 622
Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses
Muñoz-Jordán, J. L., Laurent-Rolle, M., Ashour, J., Martínez-Sobrido, L., Ashok, M., Lipkin, W. I., & García-Sastre, A. (2005) · Journal of Virology · doi:10.1128/jvi.79.13.8004-8013.2005 · Cited by 558
Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., & Pulendran, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051720 · Cited by 552
CCR5 deficiency increases risk of symptomatic West Nile virus infection
Glass, W. G., McDermott, D. H., Lim, J. K., Lekhong, S., Yu, S. F., Frank, W. A., Pape, J., Cheshier, R. C., & Murphy, P. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051970 · Cited by 519
Engels, E. A., & Pfeiffer, R. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11099 · Cited by 500
Structures of immature flavivirus particles
Zhang, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg270 · Cited by 499
Visualization of membrane protein domains by cryo-electron microscopy of dengue virus
Zhang, W., Chipman, P. R., Corver, J., Johnson, P. R., Zhang, Y., Mukhopadhyay, S., Baker, T. S., Strauss, J. H., Rossmann, M. G., & Kuhn, R. J. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb990 · Cited by 459
The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?
Gubler, D. J. (2004) · Comparative Immunology, Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2004.03.013 · Cited by 455
Dengue and dengue hemorrhagic fever : Its history and resurgence as a global public health problem
GUBLER, D. J. (1997) · Medical Entomology and Zoology · Cited by 453
THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
Theiler, M., & Smith, H. H. (1937) · Journal of Experimental Medicine · doi:10.1084/jem.65.6.787 · Cited by 445
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2004) · BMJ · doi:10.1136/bmj.38181.482222.55 · Cited by 443
Solution structure of dengue virus capsid protein reveals another fold
Ma, L., Jones, C. T., Groesch, T. D., Kuhn, R. J., & Post, C. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305892101 · Cited by 372
Structural basis of West Nile virus neutralization by a therapeutic antibody
Nybakken, G. E., Oliphant, T., Johnson, S., Burke, S., Diamond, M. S., & Fremont, D. H. (2005) · Nature · doi:10.1038/nature03956 · Cited by 352
Chambers, T. J., Weir, R. C., Grakoui, A., McCourt, D. W., Bazan, J. F., Fletterick, R. J., & Rice, C. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.8898 · Cited by 351
New Mouse Model for Dengue Virus Vaccine Testing
Johnson, A. J., & Roehrig, J. T. (1999) · Journal of Virology · doi:10.1128/jvi.73.1.783-786.1999 · Cited by 350
Population dynamics of flaviviruses revealed by molecular phylogenies.
Zanotto, P. M., Gould, E. A., Gao, G. F., Harvey, P. H., & Holmes, E. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.548 · Cited by 350
Pokidysheva, E., Zhang, Y., Battisti, A. J., Bator-Kelly, C. M., Chipman, P. R., Xiao, C., Gregorio, G. G., Hendrickson, W. A., Kuhn, R. J., & Rossmann, M. G. (2006) · Cell · doi:10.1016/j.cell.2005.11.042 · Cited by 327
Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma Interferons
Diamond, M., Roberts, T. G., Edgil, D., Lu, B., Ernst, J., & Harris, E. (2000) · Journal of Virology · doi:10.1128/.74.11.4957-4966.2000 · Cited by 325
Shresta, S., Kyle, J. L., Snider, H. M., Basavapatna, M., Beatty, P. R., & Harris, E. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.2701-2710.2004 · Cited by 320
Lindenbach, B. D., & Rice, C. M. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.4611-4621.1999 · Cited by 308
Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.
Poland, J. D., Calisher, C. H., Monath, T. P. C., Downs, W. G., & Murphy, K. (1981) · Europe PMC (PubMed Central) · Cited by 307
Self-citationA Critical Role for Induced IgM in the Protection against West Nile Virus Infection
Diamond, M. S., Sitati, E. M., Friend, L. D., Higgs, S., Shrestha, B., & Engle, M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20031223 · Cited by 303
Kümmerer, B. M., & Rice, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.4773-4784.2002 · Cited by 301
A variant in the CD209 promoter is associated with severity of dengue disease
Sakuntabhai, A., Turbpaiboon, C., Casadémont, I., Chuansumrit, A., Lowhnoo, T., Kajaste-Rudnitski, A., Kalayanarooj, S. M., Tangnararatchakit, K., Tangthawornchaikul, N., Vasanawathana, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1550 · Cited by 301
Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases
Vasconcelos, P. F., Luna, E. J., Galler, R., Silva, L. J., Coimbra, T. L., Barros, V. L., Monath, T. P., Rodigues, S. G., Laval, C., Costa, Z. G., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05326-0 · Cited by 287
Self-citationDurbin, A. P., Karron, R. A., Sun, W., Vaughn, D. W., Reynolds, M. J., Perreault, J. R., Thumar, B., Men, R., Lai, C. J., Elkins, W. R., et al. (2001) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2001.65.405 · Cited by 287
Lin, R.-J., Chang, B.-L., Yu, H.-P., Liao, C.-L., & Lin, Y.-L. (2006) · Journal of Virology · doi:10.1128/jvi.02714-05 · Cited by 286
What is Good’s syndrome? Immunological abnormalities in patients with thymoma
Kelleher, P., & Misbah, S. A. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.1.12 · Cited by 281
Antigenic Structure of Flavivirus Proteins
Roehrig, J. T. (2003) · Advances in Virus Research · doi:10.1016/s0065-3527(03)59005-4 · Cited by 279
Gabrielsen, B., Monath, T. P., Huggins, J. W., Kefauver, D. F., Pettit, G. R., Groszek, G., Hollingshead, M., Kirsi, J. J., Shannon, W. M., Schubert, E. M., et al. (1992) · Journal of Natural Products · doi:10.1021/np50089a003 · Cited by 267
Self-citationMartin, M., Tsai, T. F., Cropp, B., Chang, G.-J. J., Holmes, D. A., Tseng, J., Shieh, W.-J., Zaki, S. R., Al-Sanouri, I., Cutrona, A. F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05327-2 · Cited by 266
Lozach, P.-Y., Burleigh, L., Staropoli, I., Navarro-Sanchez, E., Harriague, J., Virelizier, J.-L., Rey, F. A., Desprès, P., Arenzana-Seisdedos, F., & Amara, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504337200 · Cited by 257
A Serologic Follow-up of the 1942 Epidemic of Post-Vaccination Hepatitis in the United States Army
Seeff, L. B., Beebe, G. W., Hoofnagle, J. H., Norman, J. E., Buskell-Bales, Z., Waggoner, J. G., Kaplowitz, N., Koff, R. S., Petrini, J. L., Schiff, E. R., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198704163161601 · Cited by 254
Hahn, C. S., Dalrymple, J. M., Strauss, J. H., & Rice, C. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.2019 · Cited by 253
The Epidemiology of Myasthenia Gravis
PHILLIPS, L. H. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1254.053 · Cited by 250
Yellow Fever: A Decade of Reemergence
Robertson, S. E. (1996) · JAMA · doi:10.1001/jama.1996.03540140045025 · Cited by 248
THE EFFECT OF PROLONGED CULTIVATION IN VITRO UPON THE PATHOGENICITY OF YELLOW FEVER VIRUS
Theiler, M., & Smith, H. H. (1937) · Journal of Experimental Medicine · doi:10.1084/jem.65.6.767 · Cited by 245
Stephens, H. A. F., Klaythong, R., Sirikong, M., Vaughn, D. W., Green, S., Kalayanarooj, S., Endy, T. P., Libraty, D. H., Nisalak, A., Innis, B. L., et al. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.600405.x · Cited by 241
Chung, K. M., Nybakken, G. E., Thompson, B. S., Engle, M. J., Marri, A., Fremont, D. H., & Diamond, M. S. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1340-1351.2006 · Cited by 241
A live, attenuated recombinant West Nile virus vaccine
Monath, T. P., Liu, J., Kanesa-Thasan, N., Myers, G. A., Nichols, R., Deary, A., McCarthy, K., Johnson, C., Ermak, T., Shin, S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601932103 · Cited by 231
Self-citationSchlesinger, J. J., Brandriss, M. W., & Walsh, E. E. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.4.2805 · Cited by 230
Hughes, R. O. (1974) · PubMed · Cited by 227
Bravo, J. R., Guzmán, M. G., & Kouri, G. P. (1987) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(87)90041-1 · Cited by 222
Langerhans Cells Migrate to Local Lymph Nodes Following Cutaneous Infection with an Arbovirus
Johnston, L. J., King, N. J. C., & Halliday, G. M. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00904.x · Cited by 219
Hepatitis B Vaccine Responsiveness in Connecticut Public Safety Personnel
Roome, A. J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510240043029 · Cited by 219
Monath, T. P., Guirakhoo, F., Nichols, R., Yoksan, S., Schrader, R., Murphy, C., Blum, P., Woodward, S., McCarthy, K., Mathis, D., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/378356 · Cited by 218
Self-citationKhromava, A. Y., Eidex, R. B., Weld, L. H., Kohl, K. S., Bradshaw, R. D., Chen, R. T., & Cetron, M. S. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.089 · Cited by 218
Monath, T. P., McCarthy, K., Bedford, P., Johnson, C. T., Nichols, R., Yoksan, S., Marchesani, R., Knauber, M., Wells, K. H., Arroyo, J., et al. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00457-1 · Cited by 217
Self-citationArroyo, J., Miller, C., Catalan, J., Myers, G. A., Ratterree, M. S., Trent, D. W., & Monath, T. P. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12497-12507.2004 · Cited by 213
Self-citationMandl, C. W., Holzmann, H., Meixner, T., Rauscher, S., Stadler, P. F., Allison, S. L., & Heinz, F. X. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2132-2140.1998 · Cited by 212
Hombach, J., Solomon, T., Kurane, I., Jacobson, J., & Wood, D. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.002 · Cited by 212
Reinhardt, B., Jaspert, R., Niedrig, M., Kostner, C., & L'age-Stehr, J. (1998) · Journal of Medical Virology · doi:10.1002/(sici)1096-9071(199810)56:2<159::aid-jmv10>3.0.co;2-b · Cited by 211
Marianneau, P., Cardona, A., Edelman, L., Deubel, V, & Desprès, P. (1997) · Journal of Virology · doi:10.1128/jvi.71.4.3244-3249.1997 · Cited by 209
Allison, S. L., Stiasny, K., Stadler, K., Mandl, C. W., & Heinz, F. X. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5605-5612.1999 · Cited by 209
Schlesinger, J. J., Brandriss, M. W., Cropp, C. B., & Monath, T. P. (1986) · Journal of Virology · doi:10.1128/jvi.60.3.1153-1155.1986 · Cited by 208
Self-citationSafe administration of influenza vaccine to patients with egg allergy
James, J. M., Zeiger, R. S., Lester, M. R., Fasano, M. B., Gern, J. E., Mansfield, L. E., Schwartz, H. J., Sampson, H. A., Windom, H. H., Machtinger, S. B., et al. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70101-5 · Cited by 208
ORAL CONTRACEPTIVES AND BLOOD-PRESSURE
Goodlin, R., & Waechter, V. (1969) · The Lancet · doi:10.1016/s0140-6736(69)92138-2 · Cited by 203
Li, W., Li, Y., Kedersha, N., Anderson, P., Emara, M., Swiderek, K. M., Moreno, G. T., & Brinton, M. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.11989-12000.2002 · Cited by 197
Guirakhoo, F., Kitchener, S., Morrison, D., Forrat, R., McCarthy, K., Nichols, R., Yoksan, S., Duan, X., Ermak, T. H., Kanesa-Thasan, N., et al. (2006) · Human Vaccines · doi:10.4161/hv.2.2.2555 · Cited by 197
Self-citationSakaguchi, M., Nakayama, T., & Inouye, S. (1996) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(96)80191-6 · Cited by 197
Determinants and Predictors of Dengue Infection in Mexico
Koopman, J. S., Prevots, D. R., Mann, M. A. V., Dantes, H. G., Aquino, M. L. Z., Longini, I. M., & Amor, J. S. (1991) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115829 · Cited by 189
Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses
Lee, E., Pavy, M., Young, N., Freeman, C., & Lobigs, M. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2005.08.006 · Cited by 185
Stiasny, K., Allison, S. L., Marchler-Bauer, A., Kunz, C., & Heinz, F. X. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8142-8147.1996 · Cited by 184
Monath, T. P., Nichols, R., Archambault, W. T., Moore, L., Marchesani, R., Tian, J., Shope, R. E., Thomas, N., Schrader, R., Furby, D., et al. (2002) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.2002.66.533 · Cited by 179
Self-citationLee, E., & Lobigs, M. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.4901-4911.2002 · Cited by 179
Tropical Infectious Diseases: Principles, Pathogens and Practice
(2011) · Elsevier eBooks · doi:10.1016/c2009-0-40410-0 · Cited by 178
Immunization of children at risk of infection with human immunodeficiency virus.
Moss, W. J., Clements, C. J., & Halsey, N. A. (2003) · Europe PMC (PubMed Central) · Cited by 177
Epitope Mapping of Flavivirus Glycoproteins
Heinz, F. X. (1986) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60263-8 · Cited by 176
Perspectives for the Treatment of Infections with Flaviviridae
Leyssen, P., De Clercq, E., & Neyts, J. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.1.67-82.2000 · Cited by 176
Mehlhop, E., & Diamond, M. S. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052388 · Cited by 175
Gould, E. A., Buckley, A., Barrett, A. D. T., & Cammack, N. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-3-591 · Cited by 172
Hall, W. C., Crowell, T. P., Watts, D. M., Barros, V. L. R., Kruger, H., Pinheiro, F., & Peters, C. J. (1991) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.45.408 · Cited by 172
Muylaert, I. R., Chambers, T. J., Galler, R., & Rice, C. M. (1996) · Virology · doi:10.1006/viro.1996.0406 · Cited by 170
Lourenço‐de‐Oliveira, R., Vazeille, M., de Filippis, A. M. B., & Failloux, A. (2003) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)00006-3 · Cited by 169
Antigenic Characteristics and Classification of Togaviridae
Porterfield, J. S. (1980) · Elsevier eBooks · doi:10.1016/b978-0-12-625380-1.50007-2 · Cited by 167
Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine
Mason, R. A., Tauraso, N. M., Spertzel, R. O., & Ginn, R. K. (1973) · Applied Microbiology · doi:10.1128/aem.25.4.539-544.1973 · Cited by 165
Schlesinger, J. J., Foltzer, M. A., & Chapman, S. (1993) · Virology · doi:10.1006/viro.1993.1015 · Cited by 163
A new mechanism for the neutralization of enveloped viruses by antiviral antibody
Gollins, S., & Porterfield, J. S. (1986) · Nature · doi:10.1038/321244a0 · Cited by 152
Guirakhoo, F., Pugachev, K., Arroyo, J., et al. (2002) · Virology · doi:10.1006/viro.2002.1462 · Cited by 150
Jardetzky, T. S., & Lamb, R. A. (2004) · Nature · doi:10.1038/427307a · Cited by 150
Fredericksen, B. L., Smith, M. W., Katze, M. G., Shi, P., & Gale, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7737-7747.2004 · Cited by 150
Spaeth, G. B., Longman, R., Albert, M. L., & Rice, C. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051352 · Cited by 147
The risk of yellow fever in a dengue-infested area
Massad, E., Coutinho, F. A. B., Burattini, M. N., & López, L. F. (2001) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(01)90184-1 · Cited by 144
Niedrig, M., Lademann, M., Emmerich, P., & Lafrenz, M. (1999) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.1999.00496.x · Cited by 143
Quaresma, J. A. S., de Barros, V. L. R. S., Pagliari, C., Fernandes, E. R., Guedes, F., Takakura, C. F. H., de Andrade, H. F., Vasconcelos, P. F. D. C., & Duarte, M. I. S. (2005) · Virology · doi:10.1016/j.virol.2005.09.058 · Cited by 143
Kurane, I., Brinton, M. A., Samson, A. L., et al. (1991) · Journal of Virology · doi:10.1128/jvi.65.4.1823-1828.1991 · Cited by 142
Innate Immune Responses to Dengue Virus
Navarro-Sánchez, E., Desprès, P., & Cedillo‐Barrón, L. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.04.007 · Cited by 140
History of thymoma and yellow fever vaccination
EIDEX, R. B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17017-7 · Cited by 139
Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination
Martin, M. A., Weld, L. H., Tsai, T. F., Mootrey, G. T., Chen, R. T., Niu, M. T., Cetron, M. S., & Group1, T. G. Y. F. W. (2001) · Emerging infectious diseases · doi:10.3201/eid0706.010605 · Cited by 139
Mandl, C. W., Allison, S. L., Holzmann, H., Meixner, T., & Heinz, F. X. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9601-9609.2000 · Cited by 139
Suzano, C. D., Amaral, E. M., SATO, H., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.09.033 · Cited by 137
Yellow fever vaccination and pregnancy: a four-year prospective study
Nasidi, A., Monath, T. P. C., Vandenberg, J. I., Tomori, O., Calisher, C. H., Hurtgen, X., Munube, G. R. R., Sorungbe, A. O. O., Okafor, G. C., & Wali, S. M. (1993) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(93)90156-k · Cited by 136
Self-citationMarotto, M. E., Thurman, R. G., & Lemasters, J. J. (1988) · Hepatology · doi:10.1002/hep.1840080325 · Cited by 135
Congenital Yellow Fever Virus Infection after Immunization in Pregnancy
Tsai, T. F., Paul, R., Lynberg, M. C., & Letson, G. W. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.6.1520 · Cited by 135
Hasegawa, H., Yoshida, M., Shiosaka, T., Fujita, S., & Kobayashi, Y. (1992) · Virology · doi:10.1016/0042-6822(92)90177-q · Cited by 134
Gollins, S., & Porterfield, J. S. (1984) · Journal of General Virology · doi:10.1099/0022-1317-65-8-1261 · Cited by 132
Yakub, I., Lillibridge, K. M., Moran, A., Gonzalez, O. Y., Belmont, J. W., Gibbs, R. A., & Tweardy, D. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/497340 · Cited by 131
Laboratory infection with Zika virus after vaccination against yellow fever
Filipe, A. R., Martins, C. L. V., & Rocha, H. (1973) · Archives of Virology · doi:10.1007/bf01556147 · Cited by 130
Muylaert, I., Galler, R., & Rice, C. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.1.291-298.1997 · Cited by 129
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins
Bredenbeek, P. J., Molenkamp, R., Spaan, W. J. M., Deubel, V., Marianneau, P., Salvato, M. S., Moshkoff, D. A., Zapata, J. C., Tikhonov, I., Patterson, J. L., et al. (2006) · Virology · doi:10.1016/j.virol.2005.12.001 · Cited by 128
Anaphylaxis from yellow fever vaccine
Kelso, J. M., Mootrey, G. T., & Tsai, T. F. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70245-9 · Cited by 125
Mathew, A., Kurane, I., Rothman, A. L., Zeng, L., Brinton, M. A., & Ennis, F. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118964 · Cited by 124
Wheelock, Ε. F., & Sibley, W. A. (1965) · New England Journal of Medicine · doi:10.1056/nejm196507222730404 · Cited by 124
Shresta, S., Kyle, J. L., Beatty, P. R., & Harris, E. (2004) · Virology · doi:10.1016/j.virol.2003.09.048 · Cited by 122
Urbanisation of yellow fever in Santa Cr uz, Bolivia
der Stuyft, P. V., Gianella, A., Pirard, M. F., Cespedes, J., Lora, J., Peredo, C., Jl, P., Vorndam, V., & Boelaert, M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03291-2 · Cited by 122
Wong, S. J., Boyle, R. H., Demarest, V. L., Woodmansee, A. N., Kramer, L. D., Li, H., DREBOT, M. A., Koski, R. A., Fikrig, E., Martin, D. A., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4217-4223.2003 · Cited by 119
Wang, E., Weaver, S. C., Shope, R. E., Tesh, R. B., Watts, D. M., & Barrett, A. D. T. (1996) · Virology · doi:10.1006/viro.1996.0601 · Cited by 116
Transovarial Transmission of Yellow Fever Virus by Mosquitoes (Aedes Aegypti)
Aitken, T. H. G., Tesh, R. B., Beaty, B. J., & Rosen, L. (1979) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1979.28.119 · Cited by 116
Molecular Amplification Assays for the Detection of Flaviviruses
Lanciotti, R. S. (2003) · Advances in virus research · doi:10.1016/s0065-3527(03)61002-x · Cited by 115
Dean, C. H., Alarcon, J. B., Waterston, A. M., et al. (2005) · Human Vaccines · doi:10.4161/hv.1.3.1797 · Cited by 113
Epidemic yellow fever caused by an incompetent mosquito vector.
Br, M., Monath, T., Wj, T., et al. (1989) · PubMed · Cited by 113
Self-citationDrug Allergy and Protocols for Management of Drug Allergies
Patterson, R., DeSwarte, R. D., Greenberger, P. A., et al. (1986) · Allergy and Asthma Proceedings · doi:10.2500/108854186779045593 · Cited by 112
Co, M. D. T., Terajima, M., Cruz, J., Ennis, F. A., & Rothman, A. L. (2002) · Virology · doi:10.1006/viro.2001.1255 · Cited by 110
Corticosteroids for treating severe sepsis and septic shock
Annane, D., Bellissant, É., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. Y. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002243.pub2 · Cited by 109
Rickets and Osteomalacia in the Glasgow Pakistani Community, 1961-71
Ford, J. A., Colhoun, E. M., McIntosh, W. B., & Dunnigan, M. G. (1972) · BMJ · doi:10.1136/bmj.2.5815.677 · Cited by 108
High Fidelity of Yellow Fever Virus RNA Polymerase
Pugachev, K. V., Guirakhoo, F., Ocran, S., Mitchell, F., Parsons, M. A., Penal, C., Girakhoo, S., Pougatcheva, S. O., Arroyo, J., Trent, D. W., et al. (2003) · Journal of Virology · doi:10.1128/jvi.78.2.1032-1038.2004 · Cited by 107
Self-citationYellow Fever 17D Vaccine Safety and Immunogenicity in the Elderly
Monath, T. P. C., Cetron, M. S., McCarthy, K., Nichols, R., Archambault, W. T., Weld, L. H., & Bedford, P. (2005) · Human Vaccines · doi:10.4161/hv.1.5.2221 · Cited by 106
Self-citationBarrett, A. D. T. (1997) · Biologicals · doi:10.1006/biol.1997.0056 · Cited by 103
SAWYER, W. A., MEYER, K. P., EATON, M. D., BAUER, J. H., PUTNAM, P., & SCHWENTKER, F. F. (1944) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a118911 · Cited by 101
Fontenille, D., Diallo, M., Mondo, M., et al. (1997) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(97)90013-4 · Cited by 100
Schlesinger, J. J., & BRANDRISS, M. W. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.127.2.659 · Cited by 96
Gagnon, S. J., Zeng, W., Kurane, I., et al. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.141-147.1996 · Cited by 95
Monath, T. P. C. (1994) · Seminars in Virology · doi:10.1006/smvy.1994.1014 · Cited by 95
Self-citationHolzmann, H., Ecker, M., Stiasny, K., Heinz, F. X., & Kunz, C. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-1-31 · Cited by 95
New developments in flavivirus vaccines with special attention to yellow fever
Pugachev, K. V., Guirakhoo, F., & Monath, T. P. C. (2005) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000178823.28585.ad · Cited by 90
Self-citationLack of both Fas Ligand and Perforin Protects from Flavivirus-Mediated Encephalitis in Mice
Luna, R. M. L., Lee, E., Müllbacher, A., Blanden, R. V., Langman, R., & Lobigs, M. (2002) · Journal of Virology · doi:10.1128/jvi.76.7.3202-3211.2002 · Cited by 90
The Anti-Yellow Fever Virus Activity of Ribavirin Is Independent of Error-Prone Replication
Leyssen, P., Clercq, E. D., & Neyts, J. H. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.020057 · Cited by 89
Membrane Permeabilization by Small Hydrophobic Nonstructural Proteins of Japanese Encephalitis Virus
Chang, Y.-S., Liao, C., Tsao, C., Chen, M.-C., Liu, C.-I., Chen, L., & Lin, Y. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6257-6264.1999 · Cited by 89
Role of Macrophages and Antibody in Resistance of Mice against Yellow Fever Virus
Rager‐Zisman, B., Wheelock, Ε. F., & ALLISON, A. C. (1971) · The Journal of Immunology · doi:10.4049/jimmunol.107.1.236 · Cited by 88
BELMUSTO-WORN, V. E., Sánchez, J. L., McCARTHY, K., Nichols, R., Bautista, C. T., Magill, A. J., PASTOR-CAUNA, G., ECHEVARRIA, C., Laguna-Torres, V. A., Samame-Talledo, B. K., et al. (2005) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2005.72.189 · Cited by 86
Self-citationLee, E., Stocks, C. E., Amberg, S. M., Rice, C. M., & Lobigs, M. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.24-32.2000 · Cited by 86
Liu, T., & Chambers, T. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2107-2118.2001 · Cited by 84
Serologic diagnosis of West Nile virus infection
Shi, P., & Wong, S. J. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.6.733 · Cited by 82
Internal proteolysis of the NS3 protein specified by dengue virus 2.
Teo, K. F., & Wright, P. J. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-2-337 · Cited by 81
Dengue and the risk of urban yellow fever reintroduction in São Paulo State, Brazil
Massad, E., Burattini, M. N., Coutinho, F. A. B., & López, L. F. (2003) · Revista de Saúde Pública · doi:10.1590/s0034-89102003000400013 · Cited by 80
Modification of the virulence of yellow fever virus by cultivation in tissues in vitro
Lloyd, W., Theiler, M., & Ricci, N. I. (1936) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(36)90002-0 · Cited by 78
Stefano, I. C. A., Sato, H. K., Pannuti, C. M., et al. (1999) · Vaccine · doi:10.1016/s0264-410x(98)00320-x · Cited by 74
Mutagenesis of the RGD Motif in the Yellow Fever Virus 17D Envelope Protein
der Most, R. G. V., Corver, J., & Strauss, J. H. (1999) · Virology · doi:10.1006/viro.1999.0026 · Cited by 73
Johnson, B. W., Kosoy, O. L., Martin, D. A., Noga, A. J., Russell, B. J., Johnson, A. A., & Petersen, L. R. (2005) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2005.5.137 · Cited by 73
Rahal, J. J., Anderson, J. F., Rosenberg, C. R., Reagan, T., & Thompson, L. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/423325 · Cited by 73
Stephen, E. L., Sammons, M. L., Pannier, W. L., Baron, S., Spertzel, R. O., & Levy, H. B. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.1.122 · Cited by 72
Falconar, A. K. I., & Young, P. R. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-4-961 · Cited by 70
Lepiniec, L., Dalgarno, L., Huong, V. T. Q., Monath, T. P. C., Digoutte, J. P., & Deubel, V. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-2-417 · Cited by 70
Self-citationHurrelbrink, R. J., & McMinn, P. C. (2001) · Journal of Virology · doi:10.1128/jvi.75.16.7692-7702.2001 · Cited by 69
McAllister, A., Arbetman, A. E., Mandl, S. J., Rossi, C. P., & Andino, R. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9197-9205.2000 · Cited by 68
Mondet, B., Vasconcelos, P. F. D. C., da Rosa, A. P. A. T., et al. (2002) · Vector-Borne and Zoonotic Diseases · doi:10.1089/153036602760260779 · Cited by 67
The safety of egg-containinq vaccines for egg-allergic patients
Miller, J., Orgel, H. A., & Meltzer, E. O. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90438-4 · Cited by 67
Yellow fever 17D as a vaccine vector for microbial CTL epitopes
Deng, T., Spaeth, G. B., Rai, U., Nussenzweig, V., Rice, C. M., & Nussenzweig, R. S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041526 · Cited by 67
Schlesinger, J. J., & Chapman, S. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-1-217 · Cited by 65
Hussain, A. I., Shanmugam, V., Switzer, W. M., Tsang, S. X., Fadly, A. M., Thea, D. M., Helfand, R. F., Bellini, W. J., Folks, T. M., & Heneine, W. (2001) · Emerging infectious diseases · doi:10.3201/eid0701.010111 · Cited by 64
Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine
Hepburn, M. J., Kortepeter, M. G., Pittman, P. R., Boudreau, E. F., Mangiafico, J. A., Buck, P. A., NORRIS, S. L. W., & Anderson, E. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.12.055 · Cited by 64
Henderson, B. E., Cheshire, P. P., Kirya, G. B., et al. (1970) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1970.19.110 · Cited by 60
Monath, T. P. C., Myers, G. A., Beck, R. A., Knauber, M., Scappaticci, K., Pullano, T. G., Archambault, W. T., Catalan, J., Miller, C., Zhang, Z.-X., et al. (2005) · Biologicals · doi:10.1016/j.biologicals.2005.03.009 · Cited by 59
Self-citationIn Vivo Synthesis of Tumor Necrosis Factor‐α in Healthy Humans after Live Yellow Fever Vaccination
Hacker, U. T., Jelı́nek, T., Erhardt, S., Eigler, A., Hartmann, G., Nothdurft, H. D., & Endres, S. (1998) · The Journal of Infectious Diseases · doi:10.1086/517806 · Cited by 58
Genetic resistance to flaviviruses
Brinton, M. A., & Perelygin, A. A. (2003) · Advances in virus research · doi:10.1016/s0065-3527(03)60002-3 · Cited by 57
Chang, G. J., Trent, D. W., Vorndam, A. V., Vergne, E., Kinney, R. M., & Mitchell, C. J. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.2.477-483.1994 · Cited by 57
Post, P. R., dos Santos, C. N. D., Carvalho, R., Cruz, A. C. R., Ricet, C. M., & Galler, R. (1992) · Virology · doi:10.1016/0042-6822(92)90745-b · Cited by 57
Khaiboullina, S. F., Rizvanov, A. A., Holbrook, M. R., & Jeor, S. S. (2005) · Virology · doi:10.1016/j.virol.2005.07.035 · Cited by 56
Gandra, Y. R., & Scrimshaw, N. S. (1961) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/9.2.159 · Cited by 55
Johnson, B. W., Chambers, T. V., Crabtree, M. B., Guirakhoo, F., Monath, T. P. C., & Miller, B. R. (2004) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.70.89 · Cited by 54
Self-citationOral Susceptibility to Yellow Fever Virus of Aedes aegypti from Brazil
Lourenço‐de‐Oliveira, R., Vazeille, M., de Filippis, A. M. B., et al. (2002) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762002000300031 · Cited by 53
Neutralization of Yellow Fever Virus Studied Using Monoclonal and Polyclonal Antibodies
Buckley, A., & Gould, E. A. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-12-2523 · Cited by 53
Diallo, M., Thonnon, J., & Fontenille, D. (2000) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2000.62.151 · Cited by 53
The Persistence of Yellow Fever Immunity.
Sawyer, W. A. (1931) · Cited by 53
Schlesinger, J. J., Chapman, S., Nestorowicz, A., Rice, C. M., Ginocchio, T. E., & Chambers, T. J. (1996) · Journal of General Virology · doi:10.1099/0022-1317-77-6-1277 · Cited by 52
Yellow fever vaccine: a successful vaccination of an immunocompromised patient
Gowda, R., Cartwright, K. E., Bremner, J., & Green, S. T. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00218.x · Cited by 50
Bhatnagar, J., Guarner, J., Paddock, C. D., Shieh, W., Lanciotti, R. S., Marfin, A. A., Campbell, G. L., & Zaki, S. R. (2006) · Journal of Clinical Virology · doi:10.1016/j.jcv.2006.11.003 · Cited by 50
The Serological Reactions in Yellow Fever
Theiler, M., & Casals, J. (1958) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1958.7.585 · Cited by 47
Epidemiological aspects of the 1969 yellow fever epidemic in Nigeria.
Carey, D. E., Kemp, G. E., Troup, J. M., et al. (1972) · PubMed · Cited by 46
Impact of Yellow Fever on The Developing World
Tomori, O. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60341-3 · Cited by 45
Quaresma, J. A. S., de Barros, V. L. R. S., Fernandes, E. R., Pagliari, C., Guedes, F., Vasconcelos, P. F. D. C., de Andrade, H. F., & Duarte, M. I. S. (2005) · Virus Research · doi:10.1016/j.virusres.2005.08.019 · Cited by 44
Association of dengue hemorrhagic fever with the HLA system.
Pérez, M. L. P., Trujillo, Y., & Otero, P. B. (1987) · PubMed · Cited by 43
STABILITY AND INFECTIVITY OF AIRBORNE YELLOW FEVER AND RIFT VALLEY FEVER VIRUSES1
MILLER, W., DEMCHAK, P., Rosenberger, C. R., Dominik, J. W., & BRADSHAW, J. L. (1963) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a120289 · Cited by 43
McElroy, K. L., Tsetsarkin, K. A., Vanlandingham, D. L., et al. (2005) · Journal of General Virology · doi:10.1099/vir.0.80746-0 · Cited by 43
Shortage of vaccines during a yellow fever outbreak in Guinea
Nathan, N., Barry, M., Herp, M. V., & Zeller, H. G. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07185-9 · Cited by 43
Immune Modulation by Flaviviruses
King, N. J. C., Shrestha, B., & Kesson, A. M. (2003) · Advances in virus research · doi:10.1016/s0065-3527(03)60004-7 · Cited by 42
Huhn, G. D., Brown, J. L., Perea, W., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.077 · Cited by 41
Postvaccinal inflammatory neuropathy: peripheral nerve biopsy in 3 cases
Vital, C., Vital, A., Gbikpi-Benissan, G., et al. (2002) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2002.02010.x · Cited by 40
Freire, M. D. S., Mann, G. F., Marchevsky, R. S., Yamamura, A. M. Y., Almeida, L. F. C., Jabor, A. V., Malachias, J. M. N., Coutinho, E. S. F., & Galler, R. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.10.035 · Cited by 37
Lefeuvre, A., Contamin, H., Decelle, T., Fournier, C., Lang, J., Deubel, V., & Marianneau, P. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.01.013 · Cited by 37
The histopathology of the liver of yellow fever‐infected rhesus monkeys
Bearcroft, W. G. C. (1957) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700740207 · Cited by 36
DNA microarray technique for detection and identification of seven flaviviruses pathogenic for man
Nordström, H., Falk, K. I., Lindegren, G., Mousavi‐Jazi, M., Waldén, A., Elgh, F., Nilsson, P., & Lundkvist, Å. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20489 · Cited by 35
Yellow Fever Vaccination, Avian Leukosis Virus, and Cancer Risk in Man
Waters, T. D., Anderson, P. S., Beebe, G. W., & Miller, R. W. (1972) · Science · doi:10.1126/science.177.4043.76 · Cited by 35
CASE REPORT: Inflammatory Causes of Gastroparesis: Report of Five Cases
Pande, H., Lacy, B. E., & Crowell, M. D. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1021036601462 · Cited by 33
Cited by
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D., Pirani, A., Gernert, K., Deng, J., Marzolf, B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,121
Sabchareon, A., Wallace, D., Sirivichayakul, C., Limkittikul, K., Chanthavanich, P., Suvannadabba, S., Jiwariyavej, V., Dulyachai, W., Pengsaa, K., Wartel, T. A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61428-7 · Cited by 818
Systems biology of vaccination for seasonal influenza in humans
Nakaya, H. I., Wrammert, J., Lee, E. K., Racioppi, L., Marie-Kunze, S., Haining, W. N., Means, A. R., Kasturi, S. P., Khan, N., Li, G.-M., et al. (2011) · Nature Immunology · doi:10.1038/ni.2067 · Cited by 809
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Gaucher, D., Therrien, R., Kettaf, N., Angermann, B. R., Boucher, G., Filali-Mouhim, A., Moser, J. M., Mehta, R. S., Drake, D. R., Castro, E., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20082292 · Cited by 594
Climate and Vectorborne Diseases
Gage, K. L., Burkot, T. R., Eisen, R. J., & Hayes, E. B. (2008) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2008.08.030 · Cited by 542
Metadata
- Authors
- Monath, T. P.
- Venue
- Expert Review of Vaccines
- Publisher
- Informa UK Limited
- Published
- 2005-08
- Volume
- 4
- Issue
- 4
- Pages
- 553-574
- ISSN
- 1476-0584 (ISSN-L)
- 1744-8395
- OpenAlex
- W2000918486
- Cited by
- 467
- References
- 223
- FWCI
- 29.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.